We are live on
!
Find out more
DSCM
Divisadero Street Capital Management Portfolio holdings
AUM
$2.39B
1-Year Est. Return
134.55%
This Fund
S&P 500
This Quarter
Est. Return
+39.48%
1 Year Est. Return
+134.55%
3 Year Est. Return
+639.6%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$346M
AUM Growth
+$118M
(+51%)
Cap. Flow
+$83.7M
Cap. Flow
% of AUM
24.19%
Top 10 Holdings %
Top 10 Hldgs %
57.82%
Holding
67
New
22
Increased
16
Reduced
4
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Transmedics
TMDX
|
+$20.3M |
| 2 |
Xponential Fitness
XPOF
|
+$16.8M |
| 3 |
Napco Security Technologies
NSSC
|
+$14.5M |
| 4 |
SI-BONE Inc
SIBN
|
+$14.1M |
| 5 |
Apyx Medical
APYX
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kura Sushi USA
KRUS
|
+$19.8M |
| 2 |
Red Robin
RRGB
|
+$13.2M |
| 3 |
Calix
CALX
|
+$11.8M |
| 4 |
Digital Turbine
APPS
|
+$9.95M |
| 5 |
Sprout Social
SPT
|
+$9.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.24% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Technology | 13.42% |
| 4 | Communication Services | 10.81% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Transmedics
TMDX
$2.91B
| $27.3M | 7.89% |
325,000
+265,000
| +442% | +$20.3M |
|
2
Fulgent Genetics
FLGT
$527M
| $25.7M | 7.42% |
693,212
+326,712
| +89% | +$11.4M |
|
|
3
SI-BONE Inc
SIBN
$834M
| $24.6M | 7.09% |
910,000
+576,942
| +173% | +$14.1M |
|
4
Tactile Systems Technology
TCMD
$665M
| $24.2M | 6.99% |
970,000
+165,000
| +20% | +$3.43M |
|
5
Celsius Holdings
CELH
$7.03B
| $20.1M | 5.82% |
405,000
+75,000
| +23% | +$2.98M |
|
|
6
Xponential Fitness
XPOF
$211M
| $18.6M | 5.38% |
1,080,000
+595,000
| +123% | +$16.8M |
|
7
Applied Digital
APLD
$8.41B
| $17.9M | 5.18% |
1,917,534
+167,534
| +10% | +$999K |
|
|
8
Napco Security Technologies
NSSC
$1.48B
| $15.6M | 4.5% |
450,000
+415,000
| +1,186% | +$14.5M |
|
9
Genius Sports
GENI
$2.11B
| $14.7M | 4.24% |
2,369,000
+1,569,000
| +196% | +$7.87M |
|
|
10
Apyx Medical
APYX
$171M
| $11.5M | 3.32% |
+2,283,958
| New | +$11.6M |
|
11
Clearfield
CLFD
$374M
| $11.5M | 3.31% |
+242,314
| New | +$10.3M |
|
|
ZIMV
12
DELISTED
ZimVie
ZIMV
| $11.2M | 3.24% |
+1,000,000
| New | +$9.71M |
|
|
EB
13
DELISTED
Eventbrite
EB
| $10.5M | 3.04% |
+1,100,000
| New | +$8.65M |
|
14
Vivid Seats
SEAT
$85.4M
| $9.5M | 2.75% |
+60,000
| New | +$9.35M |
|
15
Citi Trends
CTRN
$605M
| $8.59M | 2.48% |
+486,412
| New | +$8.38M |
|
16
InMode
INMD
$880M
| $8.22M | 2.37% |
220,000
+120,000
| +120% | +$4.19M |
|
17
BlueLinx
BXC
$706M
| $7.5M | 2.17% |
80,000
+45,000
| +129% | +$3.6M |
|
18
RingCentral
RNG
$5.28B
| $6.55M | 1.89% |
+200,000
| New | +$6.14M |
|
19
Nerdy
NRDY
$96.7M
| $5.84M | 1.69% |
1,400,000
+215,000
| +18% | +$764K |
|
20
RxSight
RXST
$260M
| $5.76M | 1.66% |
+200,000
| New | +$4.45M |
|
21
MiMedx Group
MDXG
$633M
| $5.29M | 1.53% |
+800,000
| New | +$4.08M |
|
|
22
CALL
Fulgent Genetics
FLGT
$527M
| $5.22M | 1.51% |
+141,000
| New | +$4.91M |
|
|
ASRT
23
DELISTED
Assertio
ASRT
| $4.61M | 1.33% |
56,667
+43,334
| +325% | +$4.03M |
|
24
Abercrombie & Fitch
ANF
$5B
| $4.52M | 1.31% |
+120,000
| New | +$3.42M |
|
|
CUTR
25
DELISTED
Cutera, Inc.
CUTR
| $4.26M | 1.23% |
281,684
+126,684
| +82% | +$2.4M |
|
Similar funds
RG
PA
VF
PUI
SCA
EC
HFM
CC
Divisadero Street Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Divisadero Street Capital Management held 67 positions worth $346M, up 51% from $229M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Divisadero Street Capital Management deployed $83.7M of net new capital in Q2 2023, opening 22 new positions and adding to 16 existing holdings. Its largest new stake was Apyx Medical: 2,283,958 shares worth $11.5M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was EverQuote, an estimated $3.9M trimmed.
- Divisadero Street Capital Management's largest Q2 2023 buy was Apyx Medical: 2,283,958 shares worth $11.5M.
- Divisadero Street Capital Management added most to Transmedics in Q2 2023, an estimated $20.3M increase.
- Divisadero Street Capital Management's biggest Q2 2023 reduction was EverQuote, cutting an estimated $3.9M.
- Divisadero Street Capital Management fully exited Kura Sushi USA in Q2 2023, selling an estimated $19.8M.
- Divisadero Street Capital Management's ten largest holdings make up 58% of its $346M portfolio in Q2 2023.
- Divisadero Street Capital Management opened 22 new positions and closed 24 in Q2 2023.
- Divisadero Street Capital Management's portfolio value rose 51% quarter-over-quarter to $346M.
Based on Divisadero Street Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.